anuj237
Celiac Disease Market
As per DelveInsight, there were 687,959 Celiac Disease diagnosed cases in 2019 in the United States. The Celiac Disease current market size (2020) in the United States is USD 833 Million.
Among the EU5 countries, Italy is the leading country that has the highest diagnosed cases nowadays, the diagnostic rate of Celiac Disease in Italy is much higher than in the past, mainly due to the case-finding policy adopted by doctors and greater disease awareness.
Some of the key pharma companies involved in the therapeutic market of Celiac disease and are expected to make a significant contribution in driving the Celiac disease market in the upcoming years includes 9 Meters Biopharma, Inc. BIOPHARMA, ImmunogenX, Provention Bio, Cour Pharmaceuticals Development Company, Takeda, Precigen ActoBio, Dr. Falk Pharma GmbH, and ZEDIRA GmbH.
For more details on Celiac Disease market and the promising drugs in the pipeline, visit:
www.delveinsight.com/blog/celiac-disease-market-key-compa...
Celiac Disease Market
As per DelveInsight, there were 687,959 Celiac Disease diagnosed cases in 2019 in the United States. The Celiac Disease current market size (2020) in the United States is USD 833 Million.
Among the EU5 countries, Italy is the leading country that has the highest diagnosed cases nowadays, the diagnostic rate of Celiac Disease in Italy is much higher than in the past, mainly due to the case-finding policy adopted by doctors and greater disease awareness.
Some of the key pharma companies involved in the therapeutic market of Celiac disease and are expected to make a significant contribution in driving the Celiac disease market in the upcoming years includes 9 Meters Biopharma, Inc. BIOPHARMA, ImmunogenX, Provention Bio, Cour Pharmaceuticals Development Company, Takeda, Precigen ActoBio, Dr. Falk Pharma GmbH, and ZEDIRA GmbH.
For more details on Celiac Disease market and the promising drugs in the pipeline, visit:
www.delveinsight.com/blog/celiac-disease-market-key-compa...